复制RNA疫苗:在传染病和癌症中设计,输送和免疫性
Lirui Tang1, Haiying Que1, Yuquan Wei1
1Laboratory of Aging Research and Cancer Drug Target, State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, No. 17, Block 3, Southern Renmin Road, Chengdu, 610041, Sichuan, People's Republic of China.
Journal of hematology & oncology
|April 17, 2025
概括
自复制RNA (RepRNA) 疫苗提供了一种强大的新方法来对抗传染病和癌症,通过增强抗原的产生和刺激强大,持久的免疫反应. 与传统的mRNA疫苗相比,这些先进的疫苗有望提供更广泛的保护.
科学领域:
- 疫苗学 疫苗学 疫苗学
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 复制RNA (RepRNA) 技术正在彻底改变疫苗开发.
- RepRNA疫苗利用自我复制的RNA来增强抗原呈现和免疫刺激.
- 这项技术有可能用于治疗传染病和癌症.
研究的目的:
- 探索RepRNA疫苗的设计和交付.
- 阐明通过RepRNA.RNA激活免疫系统的机制.
- 审查关于RepRNA疫苗有效性和安全性的临床前和临床数据.
主要方法:
- 利用RNA-依赖RNA聚合酶在宿主细胞内进行放大RNA复制.
- 研究诱导先天性和适应性免疫反应.
- 分析传染病和瘤的临床前模型.
- 评估关于安全性和免疫性临床试验数据.
主要成果:
- RepRNA疫苗诱导强大的,广泛的和持久的幽默和细胞免疫反应.
- 由于宿主细胞内的极端复制,增强了抗原的产生.
- 通过双链RNA生成激活先天免疫力.
- 在传染病和癌症的临床前模型中证明了保护.
结论:
- RepRNA疫苗代表了疫苗学的重大进步.
- 与传统的mRNA疫苗相比,它们引起了优越的免疫反应.
- RepRNA技术对未来对各种疾病的治疗应用具有相当大的前景.
相关概念视频
Recombinant DNA
92.8K
Overview
92.8K
Retrovirus Life Cycles
45.4K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
45.4K
Leaky Scanning
5.0K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.0K
siRNA - Small Interfering RNAs
16.3K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.3K
Experimental RNAi
6.0K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.0K
Cancer Vaccines
238
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
238


